These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 1372861)
21. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies]. Mouthon L; Bussone G; Kaveri S Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651 [TBL] [Abstract][Full Text] [Related]
30. Established and new uses of intravenous immunoglobulin. Cunningham-Rundles C Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751 [TBL] [Abstract][Full Text] [Related]
31. Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes. Schwartz SA Clin Rev Allergy; 1992; 10(1-2):1-12. PubMed ID: 1606517 [TBL] [Abstract][Full Text] [Related]
32. [Immunotherapy in non-allergic diseases]. Español T Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379 [TBL] [Abstract][Full Text] [Related]
33. Overview of the biochemistry and safety of a new native intravenous gamma globulin, IGIV, pH 4.25. Schwartz RS Am J Med; 1987 Oct; 83(4A):46-51. PubMed ID: 3118708 [TBL] [Abstract][Full Text] [Related]
34. New approaches in the therapy of immunodeficiency. Fleisher TA; Blaese RM Allergy Proc; 1993; 14(6):409-11. PubMed ID: 8157164 [No Abstract] [Full Text] [Related]
35. [Regulation of autoreactivity by the idiotypic network and therapeutic modulation of autoimmunity by polyvalent intravenous immunoglobulins (IgIV)]. Lacroix-Desmazes S; Kaveri S; Kazatchkine MD Rev Neurol (Paris); 1996 May; 152(5):349-54. PubMed ID: 8881428 [TBL] [Abstract][Full Text] [Related]
36. Safety and patient acceptability of intravenous immune globulin in 10% maltose. Ochs HD; Buckley RH; Pirofsky B; Fischer SH; Rousell RH; Anderson CJ; Wedgwood RJ Lancet; 1980 Nov; 2(8205):1158-9. PubMed ID: 6107768 [TBL] [Abstract][Full Text] [Related]
37. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders. McCormack PL BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447 [TBL] [Abstract][Full Text] [Related]
39. [Old and current aspects of intravenous immunoglobulin therapy]. Nydegger U Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191 [TBL] [Abstract][Full Text] [Related]
40. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases]. Klein M; Kaminsky P; Duc M Therapie; 1993; 48(2):97-103. PubMed ID: 8351694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]